The Industry Leader in Drug Life-Cycle InsightsIPD Analytics identifies, projects, and quantifies the impact of competitive-landscape shifts in the pharmaceutical and biologic market to offer: • Industry leading life-cycle analysis• Clinical, formulary, procurement, and inventory-control insights for payers, providers, and suppliers• Brand and generic market impact forecasts• Pharmaceutical coding and reimbursement informationWe take data from thousands of sources, combine it with proprietary research, and work to normalize, analyze, and summarize it with a unique team of experts. Utilizing that data, we develop the foundation that powers our solutions: loss-of-exclusivity timing and innovative, product-launch tracking. With this powerful foundation, meaningful, tailored insights for specific use cases are provided:• Key Litigation Updates & Analysis• Critical Headlines & Day-by-Day Trial Updates• Drug & Disease-Class Reviews• Formulary Planning Guidance • Loss-of-Exclusivity and Market-Impact Forecasts• Analogs with Qualitative Analysis• Pipeline-Planning Tools • Coding & Reimbursement Insights• Drug-Price Tools• Scenario AnalysisOur SolutionsWith subscription-based access to our proprietary platform, consultations, real-time email alerts, comprehensive reports, data downloads, podcast episodes, and more, our solutions provide actionable insights to drive decisions. An independent third-party source, IPD Analytics offers solutions that: • Deliver compelling insight and unique data assets to solve complex, multi-layered problems • Enable efficiency and transparency in an opaque pharmaceutical market• Offer a comprehensive look at the past to help predict future market shiftsPharmaceutical, Biotech, & Biosimilar Solutions:• Life-cycle Insights• Payer & Provider Insights• Coding & Reimbursement• Market & Financial Insights• Budget ImpactOther Industry Solutions:• Med-Tech Insights

Patent Analysis Litigation Monitoring Pharmaceutical Research Biotechnology Formulary Strategy Drug & Clinical Strategy Loss-of-Exclusivity Analysis Generic Drug Launches Branded Drug Launches Biosimilar Launches Market and Financial Forecasting Coding and Reimbursement Brand Drug Launches Regulatory Monitoring Drug Pipeline Intelligence Life-Cycle Management Strategy Drug Launch Analogs Biosimilar Pipeline Intelligence Drug & Clinical Strategy Information Services Information Retrieval Services